Interview by Dr Neil Love and companion faculty lecture recorded on August 28, 2026. Published September 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 1 credit
MOC types
ABIM — Medical KnowledgeUp to 1 point
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 2 South Biscayne Blvd
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- MOC · Up to 1 point
-
ReleasedOct 1, 2026
-
Last day to claim creditOct 2, 2027 12 months left
-
Research to Practice Oncology Today with Dr Neil Love: Role of CD19 x CD3 Bispecific T-Cell Engaging Antibodies in the Treatment of Acute Lymphoblastic Leukemia | 2026 (Audio Interview)
-
Research to Practice Oncology Today with Dr Neil Love: Optimizing the Use of Antibody-Drug Conjugates for Multiple Myeloma | 2026 (Lecture)
-
Research to Practice Oncology Today with Dr Neil Love: The Potential Role of TROP2- and CDH6-Directed Antibody-Drug Conjugates in Gynecologic Cancers (Interview)
-
Smart Patients +1 InterACT Oncology Team Training Integrating Bispecific Antibodies Into PatientCentered Management of DLBCLEnhancing the PatientProvider Therapeutic Connection
-
Plexus Communications +1 Contemporary B-ALL Care: Practical Integration and Use of CD19-Directed Bispecific Antibodies
-
Answers in CME Inc. (AiCME) Evolving Care in B-ALL: From Questions to Answers on The Role of CD19 Bispecific T-Cell Engagers
